The Cooper Companies, Inc. Common Stock — Rendiconto Finanziario Trimestrale (NASDAQ:COO)

Apri il grafico completo

Financials

Panoramica Estratto Conto Statistiche Dividendi

Trimestrale Annuale

Market Capitalization 13.71 B
Employee 15 K
Founded N/A
CEO Albert G. White III
Website www.coopercos.com
Headquarter Delaware, United States
FIGI BBG000BG3445
Industry Technology

Ricavi totali

Utile netto

Utile base per azione (EPS base)

Debito totale

Liquidità libera

Disponibilità liquide e mezzi equivalenti

13.71 B Capitalizzazione di mercato

Rapporto prezzo/utili

40.12

Rapporto prezzo/fatturato

3.87

Dividendi per azione

—

Rendimento da dividendi %

—

The Cooper Companies Inc

The Cooper Companies, Inc., branded as CooperCompanies, is a global medical device company headquartered in San Ramon, California. The company consists of two business units, CooperVision which manufactures contact lenses, and CooperSurgical, which manufactures medical devices and fertility and genomic products for the women's healthcare market.

COO

Financials

The Cooper Companies Inc

Notizie

Gli azionisti di Cooper Companies eleggono i direttori e approvano le proposte all’assemblea annuale

Why The Cooper Companies (COO) is a Top Growth Stock for the Long-Term

Reasons to Add Cooper Companies Stock to Your Portfolio Now

Touchstone Mid Cap Fund Q4 2025 Portfolio Review

Here's Why You Should Add Merit Medical Stock to Your Portfolio Now

The Cooper Companies (COO) Loses 8.8% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Why The Cooper Companies (COO) is a Top Value Stock for the Long-Term

Investing in The Cooper Companies (COO)? Don't Miss Assessing Its International Revenue Trends

Is The Cooper Companies (COO) a Solid Growth Stock? 3 Reasons to Think "Yes"

Here's Why The Cooper Companies (COO) is a Strong Growth Stock

COO Declines Despite Q1 Earnings Beat and Raised FY26 Outlook

Needham alza il target di prezzo di Cooper Companies per i guadagni sui margini